Literature DB >> 31031142

Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites.

Dan E McNamara1, Cole M Dovey2, Andrew T Hale3, Giovanni Quarato4, Christy R Grace5, Cristina D Guibao1, Jonathan Diep2, Amanda Nourse6, Casey R Cai1, Hong Wu5, Ravi C Kalathur5, Douglas R Green4, John D York3, Jan E Carette7, Tudor Moldoveanu8.   

Abstract

Necroptosis is an inflammatory form of programmed cell death executed through plasma membrane rupture by the pseudokinase mixed lineage kinase domain-like (MLKL). We previously showed that MLKL activation requires metabolites of the inositol phosphate (IP) pathway. Here we reveal that I(1,3,4,6)P4, I(1,3,4,5,6)P5, and IP6 promote membrane permeabilization by MLKL through directly binding the N-terminal executioner domain (NED) and dissociating its auto-inhibitory region. We show that IP6 and inositol pentakisphosphate 2-kinase (IPPK) are required for necroptosis as IPPK deletion ablated IP6 production and inhibited necroptosis. The NED auto-inhibitory region is more extensive than originally described and single amino acid substitutions along this region induce spontaneous necroptosis by MLKL. Activating IPs bind three sites with affinity of 100-600 μM to destabilize contacts between the auto-inhibitory region and NED, thereby promoting MLKL activation. We therefore uncover MLKL's activating switch in NED triggered by a select repertoire of IP metabolites.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRISPR Cas9 gene editing; MLKL; NMR structure determination; cell death; inositol phosphate; inositol phosphate kinase; membrane permeabilization; metabolite; necroptosis; plasma membrane rupture

Mesh:

Substances:

Year:  2019        PMID: 31031142      PMCID: PMC6588482          DOI: 10.1016/j.chembiol.2019.03.010

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  100 in total

Review 1.  Back in the water: the return of the inositol phosphates.

Authors:  R F Irvine; M J Schell
Journal:  Nat Rev Mol Cell Biol       Date:  2001-05       Impact factor: 94.444

2.  Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA.

Authors:  Torsten Herrmann; Peter Güntert; Kurt Wüthrich
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

3.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

4.  Specificity determinants in inositol polyphosphate synthesis: crystal structure of inositol 1,3,4-trisphosphate 5/6-kinase.

Authors:  Gregory J Miller; Monita P Wilson; Philip W Majerus; James H Hurley
Journal:  Mol Cell       Date:  2005-04-15       Impact factor: 17.970

5.  Inositide evolution - towards turtle domination?

Authors:  Robin F Irvine
Journal:  J Physiol       Date:  2005-04-28       Impact factor: 5.182

6.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

Authors:  P Schuck
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

7.  The human homologue of yeast ArgRIII protein is an inositol phosphate multikinase with predominantly nuclear localization.

Authors:  Marcus M Nalaskowski; Christina Deschermeier; Werner Fanick; Georg W Mayr
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

8.  The human homolog of the rat inositol phosphate multikinase is an inositol 1,3,4,6-tetrakisphosphate 5-kinase.

Authors:  Shao-Chun Chang; Aimee L Miller; Yucheng Feng; Susan R Wente; Philip W Majerus
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

9.  A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.

Authors:  Lin Li; Ranny Mathew Thomas; Hidetaka Suzuki; Jef K De Brabander; Xiaodong Wang; Patrick G Harran
Journal:  Science       Date:  2004-09-03       Impact factor: 47.728

10.  Structure of a human inositol 1,4,5-trisphosphate 3-kinase: substrate binding reveals why it is not a phosphoinositide 3-kinase.

Authors:  Beatriz González; Michael J Schell; Andrew J Letcher; Dmitry B Veprintsev; Robin F Irvine; Roger L Williams
Journal:  Mol Cell       Date:  2004-09-10       Impact factor: 17.970

View more
  14 in total

1.  Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL.

Authors:  Ashish Sethi; Christopher R Horne; Cheree Fitzgibbon; Karyn Wilde; Katherine A Davies; Sarah E Garnish; Annette V Jacobsen; André L Samson; Joanne M Hildebrand; Ahmad Wardak; Peter E Czabotar; Emma J Petrie; Paul R Gooley; James M Murphy
Journal:  Cell Death Differ       Date:  2022-03-09       Impact factor: 12.067

2.  Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using Monobodies.

Authors:  Emma J Petrie; Richard W Birkinshaw; Akiko Koide; Eric Denbaum; Joanne M Hildebrand; Sarah E Garnish; Katherine A Davies; Jarrod J Sandow; Andre L Samson; Xavier Gavin; Cheree Fitzgibbon; Samuel N Young; Patrick J Hennessy; Phoebe P C Smith; Andrew I Webb; Peter E Czabotar; Shohei Koide; James M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-31       Impact factor: 11.205

Review 3.  Inositol Polyphosphate Multikinase Signaling: Multifaceted Functions in Health and Disease.

Authors:  Boah Lee; Seung Ju Park; Sehoon Hong; Kyunghan Kim; Seyun Kim
Journal:  Mol Cells       Date:  2021-04-30       Impact factor: 5.034

4.  Metabolic supervision by PPIP5K, an inositol pyrophosphate kinase/phosphatase, controls proliferation of the HCT116 tumor cell line.

Authors:  Chunfang Gu; Juan Liu; Xiaojing Liu; Haibo Zhang; Ji Luo; Huanchen Wang; Jason W Locasale; Stephen B Shears
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 12.779

Review 5.  MLKL: Functions beyond serving as the Executioner of Necroptosis.

Authors:  Chaoning Zhan; Minchun Huang; Xiaojun Yang; Jin Hou
Journal:  Theranostics       Date:  2021-03-04       Impact factor: 11.556

Review 6.  The Killer Pseudokinase Mixed Lineage Kinase Domain-Like Protein (MLKL).

Authors:  James M Murphy
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-08-03       Impact factor: 9.708

7.  Primate lentiviruses require Inositol hexakisphosphate (IP6) or inositol pentakisphosphate (IP5) for the production of viral particles.

Authors:  Clifton L Ricana; Terri D Lyddon; Robert A Dick; Marc C Johnson
Journal:  PLoS Pathog       Date:  2020-08-10       Impact factor: 6.823

8.  A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.

Authors:  Soren L Faergeman; Hayley Evans; Kathrine E Attfield; Christiane Desel; Subita Balaram Kuttikkatte; Mette Sommerlund; Lise Torp Jensen; Jorgen Frokiaer; Manuel A Friese; Paul M Matthews; Christian Luchtenborg; Britta Brügger; Annette Bang Oturai; Calliope A Dendrou; Lars Fugger
Journal:  Cell Death Dis       Date:  2020-05-01       Impact factor: 8.469

Review 9.  Partners in Crime: The Interplay of Proteins and Membranes in Regulated Necrosis.

Authors:  Uris Ros; Lohans Pedrera; Ana J Garcia-Saez
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

Review 10.  Current translational potential and underlying molecular mechanisms of necroptosis.

Authors:  Tamás Molnár; Anett Mázló; Vera Tslaf; Attila Gábor Szöllősi; Gabriella Emri; Gábor Koncz
Journal:  Cell Death Dis       Date:  2019-11-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.